WEBSITECHANGES

Website Changes

---

09/20/2022

New Radiation Therapy Delays Brain Cancer Regrowth, Protects Healthy Tissue

---

09/15/2022

Brain Tumor Guide For The Newly Diagnosed - new Kindle Edition available!

---

09/15/2022

SonALAsense Forges Ahead with First Patient Dosing for Devastating Childhood Brain Cancer

---

09/11/2022

Cancer Chomp (a brain tumor event)

---

09/09/2022

Musella Foundation Brain Tumor Treatment Copayment Assistance program is now closed to new patients

---

09/08/2022

Cancer Commons Presents Free Webinar on Biomarker Testing and Why it Matters

---

09/06/2022

IQ-AI`s trial investigator talks through the importance of its brain cancer treatment

---

09/06/2022

Musella Foundation awards another brain tumor research grant!

---

08/26/2022

xCures and Oblato announce the launch of a Compassionate Use program for OKN-007

---

08/24/2022

Musella Foundation Awards Two More Brain Tumor Research Grants!

---

08/21/2022

Intratumoral oncolytic herpes virus G47? for residual or recurrent glioblastoma: a phase 2 trial

---

08/21/2022

Local musician fights cancer to get back to doing what he loves

---

08/16/2022

Phase I trial of adjuvant mature autologous dendritic cell/allogeneic tumor lysate vaccines in combination with temozolomide in newly diagnosed glioblastoma

---

08/16/2022

Molecular alterations associated with improved outcome in patients with glioblastoma treated with Tumor-Treating Fields

---

08/16/2022

Serial H3K27M cell-free tumor DNA (cf-tDNA) tracking predicts ONC201 treatment response and progression in diffuse midline glioma

---

08/15/2022

Cancer Commons and Musella Foundation For Brain Tumor Research Launch Pilot Study of Individualized Treatments for GBM

---

08/15/2022

Musella Foundation Awards Two More Brain Tumor Research Grants!

---

08/11/2022

Upfront Biology-Guided Therapy in Diffuse Intrinsic Pontine Glioma: Therapeutic, Molecular, and Biomarker Outcomes from PNOC003

---

08/09/2022

National Walk To End Brain Tumors to be held Sept 24, 2022 in New Egypt, NJ

---

08/08/2022

Parents demand new brain cancer drug be made available in Australia

---

08/01/2022

Musella Foundation Copayment Assistance Program is now open to new and renewal patients!

---

08/01/2022

Introduction to ROON!

---

08/01/2022

Kazia Therapeutics : PROVIDES PROGRESS UPDATE ON GBM AGILE PIVOTAL STUDY

---

07/30/2022

Intratumoral oncolytic herpes virus G47? for residual or recurrent glioblastoma: a phase 2 trial

---

07/30/2022

Continuing maintenance temozolomide therapy beyond 12 cycles confers no clinical benefit over discontinuation at 12 cycles in patients with IDH1/2-wildtype glioblastoma

---